While TB can be treated with the right medication, there are some big obstacles involved. One of the biggest is the increasing number of drug-resistant tuberculosis strains. That’s something researchers at Brock University in Ontario, Canada have been working to help with. With this goal in mind, they have developed microscopic nanobots capable of determining whether a blood sample not only contains the tuberculosis bacteria — but also bacteria with the necessary mutations to make it drug-resistant.

Image Credit:   Brock University

News This Week

Liquid Lightning: Nanotechnology Unlocks New Energy

EPFL researchers have discovered that nanoscale devices harnessing the hydroelectric effect can harvest electricity from the evaporation of fluids with higher ion concentrations than purified water, revealing a vast untapped energy potential. Evaporation is a natural [...]